
1. clin j gastroenterol. 2015 aug;8(4):167-71. doi: 10.1007/s12328-015-0590-y. epub 
2015 aug 12.

future therapy hepatitis b virus infection.

minami m(1).

author information: 
(1)aiseikai yamashina hospital, kyoto, japan, minami@koto.kpu-m.ac.jp.

we control hepatitis b virus infection continuously administering
nucleoside nucleotide analogues entecavir tenofovir. drugs 
are generally safe sufficiently effective, future drugs needed that
can show off-treatment efficacy--in words, eradication latent hepatitis 
b virus dna (covalently closed circular dna) hepatocytes. article 
an overview new drugs development novel strategies inhibit
hepatitis b virus proliferation.

doi: 10.1007/s12328-015-0590-y 
pmid: 26265385  [indexed medline]

